文獻發表支援

APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.

 2017 Sep 6;8(1):465. doi: 10.1038/s41467-017-00493-9.

Chen, T.W., Lee, C.C., Liu, H., Wu, C.S., Pickering, C.R., Huang, P.J., Wang, J., Chang, I.Y., Yeh, Y.M., Chen, C.D., Li, H.P., Luo, J.D., Tan, B.C., Chan, T.E.H., Hsueh, C., Chu, L.J., Chen, Y.T., Zhang, B., Yang, C.Y., Wu, C.C., Hsu, C.W., See, L.C., Tang, P., Yu, J.S., Liao, W.C., Chiang, W.F., Rodriguez, H., Myers, J.N., Chang, K.P., Chang, Y.S.

[PubMed]

In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.

 2015 Apr;14(4):917-32. doi: 10.1074/mcp.M114.045914. Epub 2015 Jan 31.

Liu, P.J., Chen, C.D., Wang, C.L., Wu, Y.C., Hsu, C.W., Lee, C.W., Huang, L.H., Yu, J.S., Chang, Y.S., Wu, C.C., and Yu, C.J.

[PubMed]

Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.

 2014 Jun 6;13(6):2818-29. doi: 10.1021/pr4012377. Epub 2014 May 14.

Chen, C. D., Wang, C. L., Yu, C. J., Chien, K. Y., Chen, Y. T., Chen, M. C., Chang, Y. S., Wu, C. C., and Yu, J. S.

[PubMed]

Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.

J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.

Chen, C. L., Lai, Y. F., Tang, P., Chien, K. Y., Yu, J. S., Tsai, C. H., Chen, H. W., Wu, C. C., Chung, T., Hsu, C. W., Chen, C. D., Chang, Y. S., Chang, P. L., and Chen, Y. T.

[PubMed]

Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology.

J Proteome Res. 2011 Oct 7;10(10):4671-82. doi: 10.1021/pr2004743. Epub 2011 Aug 24.

Yu, C. J., Wang, C. L., Wang, C. I., Chen, C. D., Dan, Y. M., Wu, C. C., Wu, Y. C., Lee, I. N., Tsai, Y. H., Chang, Y. S., and Yu, J. S.

[PubMed]

Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.

Mol Cell Proteomics. 2010 Jun;9(6):1100-17. doi: 10.1074/mcp.M900398-MCP200. Epub 2010 Feb 1.

Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J., Chang, K. P., Tai, D. I., Liu, H. P., Su, W. H., Chang, Y. S., and Yu, J. S.

[PubMed]

Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology.

J Proteome Res. 2010 Nov 5;9(11):5803-15. doi: 10.1021/pr100576x. Epub 2010 Sep 17.

Chen, Y. T., Chen, C. L., Chen, H. W., Chung, T., Wu, C. C., Chen, C. D., Hsu, C. W., Chen, M. C., Tsui, K. H., Chang, P. L., Chang, Y. S., and Yu, J. S.

[PubMed]

Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance.

Proteomics. 2007 Jan;7(1):155-67.

Chen, C. D., Wang, C. S., Huang, Y. H., Chien, K. Y., Liang, Y., Chen, W. J., and Lin, K. H.

[PubMed]